64.1 F
Laguna Hills
Saturday, Jul 2, 2022
-Advertisement-
-Advertisement-

Skin Cancer Drug News Boosts Bristol Shares

- Advertisement -

Bristol-Myers Squibb Co.’s shares rose more than 7 percent on Monday after news over the weekend that its experimental drug ipilimumab extended survival in patients with deadly skin cancer.

*For more on this story, read the full Reuters article.

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-